Weekly Analysts’ Ratings Updates for Revvity (RVTY)

Revvity (NYSE: RVTY) recently received a number of ratings updates from brokerages and research firms:

• 2/3/2026 – Revvity was given a new $129.00 price target on by analysts at Robert W. Baird.
• 2/3/2026 – Revvity had its “hold” rating reaffirmed by analysts at TD Cowen.
• 2/3/2026 – Revvity had its price target raised by analysts at Evercore ISI from $112.00 to $118.00. They now have an “outperform” rating on the stock.
• 2/3/2026 – Revvity had its price target raised by analysts at Barclays PLC from $115.00 to $118.00. They now have an “overweight” rating on the stock.
• 2/3/2026 – Revvity had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $105.00. They now have a “neutral” rating on the stock.
• 2/3/2026 – Revvity had its price target raised by analysts at TD Cowen from $120.00 to $124.00. They now have a “buy” rating on the stock.
• 2/3/2026 – Revvity had its price target raised by analysts at Wells Fargo & Company from $107.00 to $110.00. They now have an “equal weight” rating on the stock.
• 2/2/2026 – Revvity had its price target raised by analysts at Jefferies Financial Group Inc. from $100.00 to $105.00. They now have a “hold” rating on the stock.
• 1/5/2026 – Revvity had its “outperform” rating reaffirmed by analysts at Evercore ISI.
• 12/29/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Revvity had its price target raised by analysts at Wells Fargo & Company from $102.00 to $107.00. They now have an “equal weight” rating on the stock.
• 12/15/2025 – Revvity had its price target raised by analysts at Barclays PLC from $105.00 to $115.00. They now have an “overweight” rating on the stock.
• 12/15/2025 – Revvity was downgraded by analysts at Bank of America Corporation from a “buy” rating to a “neutral” rating. They now have a $110.00 price target on the stock.
• 12/9/2025 – Revvity is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $105.00 price target on the stock.
• 12/9/2025 – Revvity is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $105.00 price target on the stock.
• 12/8/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s payout ratio is 14.07%.

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.